Aphria is a licensed medical cannabis company that is owned and operated by highly experienced greenhouse growers who have been growing flowers and vegetables.

Aphria has been setting the standard for safe, clean and pure pharmaceutical-grade cannabis at scale, grown in the most natural conditions possible. 

Aphria was founded in 2013 by John Cervini & Cole Cacciavillani. The company is headquartered in Leamington, Ontario, Canada.

Aphria leads the medical cannabis industry through unparalleled quality, value, customer-focused service, and a commitment to accountability. Since day one, delivering an expertly crafted product has been the cornerstone of our business. We go above and beyond in every aspect of our work, because we exist to improve our patients’ quality of life.

Aphria runs a greenhouse to produce cannabis in Leamington, Ontario, called Aphria One. As of August 2018, Aphria One was responsible for 90% of Aphria's production, and had 300,000 square feet of production space. The company is also building another greenhouse in the Leamington area, Aphria Diamond, in partnership with Double Diamond, a greenhouse operator. It is backed in part by the Delavaco Group, a private equity firm. 


In January 2018, Aphria agreed to take over Broken Coast Cannabis, a Vancouver Island cannabis producer, for $230 million in cash and stock. Also in January 2018, Aphria agreed to purchase Nuuvera, a Brampton-based cannabis company, for $826 million.



  • Year founded: 2013
  • Funding Info: $110.8M in 4 funding rounds (Last funding type: Undisclosed)
  • Yearly Revenue: $100M-$200M (2018)
  • Employee Size: 501-1,000
  • Business Valuation: Mkt Cap: 3.33B (CAD) as of Apr 05, 2019
  • City/Town: Leamington
  • State: Ontario
  • Country: Canada
Related businesses